Table 4.
Proposed age-based dosing schedules for children 1–11 months old based on results from the MORDOR morbidity and CHAT trials*
Tiers | Age group (months) |
Dose | % Within limits | |
MORDOR (n=4103) | CHAT (n=5498) | |||
2 | 1–2 | 80 mg (2 mL) | 93.4% | 89.4% |
3–11 | 160 mg (4 mL) | |||
3 | 1–2 | 80 mg (2 mL) | 94.2% | 92.5% |
3–4 | 120 mg (3 mL) | |||
5–11 | 160 mg (4 mL) |
*Assuming tolerance limits of 10–20 mg/kg for children 1–2 months old and 15–30 mg/kg for children 3–11 months old.
CHAT, Child Health with Azithromycin Treatment; MORDOR, Macrolides Oraux pour le Réduire des Décès avec un Oeil sur la Résistance.